Marimed (MRMD) Cash from Investing Activities (2012 - 2026)

Marimed (MRMD) has 15 years of Cash from Investing Activities data on file, last reported at -$753000.0 in Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$753000.0, down 554.78% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.0 million (up 84.46% YoY), and the FY2025 annual result was -$1.4 million, up 91.95% from the prior year.
• Cash from Investing Activities eased to -$753000.0 in Q1 2026 per MRMD's latest filing, from -$197000.0 in the prior quarter.
• Over five years, Cash from Investing Activities peaked at -$115000.0 in Q1 2025 and troughed at -$16.7 million in Q2 2022.
• A 5-year average of -$4.2 million and a median of -$2.6 million in 2022 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities surged 97.3% in 2025, then plunged 554.78% in 2026.
• A 5-year view of Cash from Investing Activities shows it stood at -$2.5 million in 2022, then plunged by 152.61% to -$6.3 million in 2023, then surged by 81.1% to -$1.2 million in 2024, then soared by 83.58% to -$197000.0 in 2025, then tumbled by 282.23% to -$753000.0 in 2026.
• Business Quant data shows MRMD's Cash from Investing Activities at -$753000.0 in Q1 2026, -$197000.0 in Q4 2025, and -$514000.0 in Q3 2025.